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Longitudinal Flow Gradient for the
Identiﬁcation of Coronary Artery DiseaseInes Valenta, MD,* Alessandra Quercioli, MD,y Thomas H. Schindler, MD*
Baltimore, Maryland; and Geneva, SwitzerlandOBJECTIVES The purpose of this study was to evaluate the diagnostic value of a positron emission
tomography (PET)/computed tomography (CT)–determined longitudinal decrease in myocardial blood
ﬂow (MBF) gradient during hyperemia and myocardial ﬂow reserve (MFR) for the identiﬁcation of epicar-
dial stenosis $50%.
BACKGROUND Although PET-determined reductions in MFR are increasingly applied to identify
epicardial lesions in coronary artery disease (CAD), it may be seen as a suboptimal approach due to
the nonspeciﬁc origin of decreases in MFR.
METHODS In 24 patients with suspected or known CAD, MBF was measured with 13N-ammonia and
PET/CT in ml/g/min at rest, during dipyridamole stimulation, and the corresponding MFR was calculated.
MBF was also determined in the mid and mid-distal myocardium of the left ventricle (LV). A decrease in
MBF from mid to mid-distal LV myocardium was deﬁned as longitudinal MBF gradient. MBF parameters
were determined in the myocardial region with stress-induced perfusion defect and with stenosis $50%
(territory 1), without defect but with stenosis $50% (territory 2), or without stenosis $50% (territory 3).
RESULTS In territories 1 and 2 with focal stenosis $50%, the severity of epicardial artery stenosis
correlated with the Dlongitudinal MBF gradient (stress-rest) (r ¼ 0.52; p < 0.0001), while this association
was less pronounced for corresponding MFR (r ¼ 0.40; p < 0.003). On a vessel-based analysis, the sensi-
tivity and speciﬁcity of the Dlongitudinal MBF gradient in the identiﬁcation of epicardial lesions was
higher than those for MFR (88% vs. 71%, p# 0.044; and 81% vs. 63%, p ¼ 0.134, respectively). Combining
both parameters resulted in an optimal sensitivity of 100% and intermediate speciﬁcity of 75%. The diag-
nostic accuracy was highest for the combined analysis than for the Dlongitudinal MBF gradient or MFR
alone (94% vs. 86%, p # 0.003; and 94% vs. 70%, p # 0.0002).
CONCLUSIONS The combined evaluation of a Dlongitudinal MBF gradient and MFR may evolve as
a new promising analytic approach to further optimize the identiﬁcation of CAD lesions. (J Am Coll
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CAD = coronary artery dise
CT = computed tomograph
CVR = coronary vascular
resistance
LAD = left anterior descen
LCx = left circumﬂex
LV = left ventricular
MBF = myocardial blood ﬂ
MFR = myocardial ﬂow res
PET = positron emission
tomography
RCA = right coronary arter
ROC = receiver-operating
characteristic
RPP = rate-pressure produ
SDS = summed difference
SSS = summed stress score
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388ssessment of left ventricular (LV) myocar- (Table 1). Quantitative coronary angiography was
dial blood ﬂow (MBF) at rest, during
pharmacologically stimulated hyperemia,
and the resulting myocardial ﬂow reserve
(MFR) with positron emission tomography (PET)
or PET/computed tomography (CT) is increasingly
applied to assess the ﬂow-limiting effects of single
lesions in multivessel coronary artery disease (CAD)
(1–4). Such noninvasively-obtained information on
hyperemic MBF and MFR has also been demon-
strated to carry important prognostic information in
patients with and without clinically-manifest CAD
(5–7). Reductions in MFR in CAD patients,
however, may be interpreted not only as a conse-
quence of ﬂow-limiting effects of epicardial stenosis,
if present, but also in the context of microvascularase
y
ding
ow
erve
y
ct
scoredysfunction (3,7). Due to the relatively
low speciﬁcity of reduced MFR (7,8), a
clear identiﬁcation of ﬂow-limiting effects
of epicardial lesions in the individual CAD
patient sometimes may remain uncertain.
In this direction, PET ﬂow measurements
of an abnormal decrease in MBF from the
base to the apex of the LV during hyper-
emic ﬂows, a so-called ﬂow gradient, has
been suggested to provide more detailed
information on structural and functional
alterations of epicardial artery in cardio-
vascular risk individuals (9–12). This
proximal-to-distal ﬂow gradient has been
attributed to ﬂuid dynamic consequences
of CAD-induced diffuse luminal narrow-
ing or to functional alterations of the epi-
cardial coronary conduit vessels (9,10,13).
As the longitudinal MBF gradient is
assumed to be related predominantly to
increases in epicardial resistance duringhyperemic ﬂows (12,13), it may provide more spe-
ciﬁc information on ﬂow-limiting effects of epicar-
dial stenosis than the conventional interpretation of
MFR alone. According to this, we aimed to deter-
mine the diagnostic value of a PET/CT-determined
longitudinal decrease in MBF (MBF gradient)
during hyperemia and MFR for the identiﬁcation
of epicardial stenosis $50% in CAD patients.
METHODS
Patient population. The study population comprised
24 patients (18 men, 6 women; mean age 67 
10 years) with stress-induced regional myocardial
perfusion defects on 13N-ammonia PET/CT images.
Within 20 days of PET perfusion imaging, these
patients underwent invasive coronary angiographyperformed to assess the severity of epicardial lesions
identiﬁed during invasive coronary angiography.
Patients were considered for study purposes, if
coronary artery lesions of $50% diameter stenosis
were located in the proximal part of the left anterior
descending (LAD) (segments 12 to 13), left
circumﬂex (LCx) (segments 18 to 19), and right
coronary artery (RCA) (segments 1 to 3) according
to the American College of Cardiology/American
Heart Association guidelines (14). All CAD pa-
tients had normal wall motion on angiographic
evaluation. In addition, 34 healthy individuals
without known cardiovascular risk factors and nor-
mal stress-rest 13N-ammonia PET/CT perfusion
imaging served as a control group (Table 1). Car-
diovascular risk factors included the presence of
arterial hypertension, smoking, type 2 diabetes
mellitus, hypercholesterolemia, or family history of
CAD. Patients with evidence of left ventricular
hypertrophy on echocardiography were excluded
from study analysis. Vasoactive medications such as
calcium-channel blockers, angiotensin-converting
enzyme inhibitors, statins, as well as beta-blockers,
and diuretics were discontinued at least 24 h
before PET ﬂow study. All study participants
refrained from caffeine-containing beverages for
$24 h and from smoking for $12 h prior to the
PET study. The study was approved by the Uni-
versity Hospitals of Geneva Institutional Review
Board (No. 07-184), and each participant signed
the approved informed consent form.
PET/CT ﬂow investigations. Myocardial perfusion
and MBF, measured in ml/min/g, were assessed
with 13N-ammonia PET/CT, serial PET image
acquisition (64-slice Biograph, HiRez TruePoint
PET-CT scanner, Siemens Medical Solutions,
Erlangen, Germany), and a 2-compartment tracer
kinetic model, as described in detail previously (12).
Pharmacologic vasodilation to stimulate hyperemic
MBF increases was performed with standard infu-
sion of dipyridamole (140 mg/kg/min). Myocardial
perfusion at rest and during pharmacologic vasodi-
lation was analyzed visually on reoriented short- and
long-axis myocardial slices and semiquantitatively
on the corresponding polar map from the last static
18-min transaxial PET image. For the semi-
quantitative analysis of the PET perfusion images,
a 17-segment model and a 5-point grading system
by 2 expert observers were applied (12). Summed
stress score (SSS), summed rest score, and summed
difference score (SDS) were calculated. An SSS
<4 was considered normal, 4 to 8 mildly abnormal,
9 to 13 moderately abnormal, and >13 severely
Table 1. Clinical Characteristics of the Study Population
Control Individuals
(n [ 34)
CAD Patients
(n [ 24) p Values
Age, yrs 39 (32, 45) 56 (52, 59) 0.0001
BMI, kg/m2 22 (21, 26) 30 (27, 34) 0.0001
Risk factors
Hypertension 0 (0) 11 (45) d
Smoking 0 (0) 9 (37) d
Hypercholesterolemia 0 (0) 13 (54) d
Obesity 0 (0) 5 (21) d
Family history of CAD 0 (0) 4 (17) d
Diabetes mellitus 0 (0) 7 (29) d
Fasting plasma concentrations, mg/dl
Cholesterol 206 (167, 230) 227 (209, 240) 0.014
LDL 125 (102, 146) 140 (123, 163) 0.027
HDL 49 (36, 71) 39 (33, 48) 0.030
TG 74 (54, 168) 98 (67, 178) 0.198
Glucose 90 (84, 102) 113 (102, 123) 0.001
hsCRP 1.0 (0.9, 2.0) 8.5 (0.8, 17.7) 0.013
Values are median (Q1, Q3) or n (%). p values versus control individuals (Mann-Whitney U test
for independent samples).
BMI ¼ body mass index; CAD ¼ coronary artery disease; HDL ¼ high-density lipoprotein; hsCRP ¼ high-
sensitivity C-reactive protein; LDL ¼ low-density lipoprotein; TG ¼ triglycerides.
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389abnormal perfusion defect. Further, a SDS $2
identiﬁed a reversible perfusion defect, whereas <2
was considered as normal. The extent of regional
reversible perfusion defects on 13N-ammonia PET/
CT images was graded according to the SDS value.
Accordingly, an SDS of 2 to 4, >5 to 8, and >8
deﬁned mild, moderate, and severe reversible
perfusion defects, respectively. Regional MBFs of
the 3 main myocardial territories subtended to the
LAD, LCx, and RCA were averaged on a polar
map, and the resulting mean MBF of the LV was
deﬁned as global MBF. Subsequently, longitudinal
MBFs in the mid and mid-distal myocardial
segment of the LV corresponding to the vascular
territories of the LAD (segments: 7 to 8 and 13 to
14), LCx (segments: 11 to 12 and 16), and RCA
(segments: 9 to 10 and 15) were determined. Basal
segments (LAD: 1 to 2, LCx: 5 to 6, and RCA: 3
to 4) and the apical segment (LAD: 17), however,
were not included for this analysis due to a possible
count variability induced by the membranous
septum, by a certain variability in locating the last
apical slice, and by partial volume errors resulting
from object size at the apex (9). Heart rate, blood
pressure, and a 12-lead electrocardiogram were
recorded continuously during each MBF measure-
ment. From the average of heart rate and systolic
blood pressure during the ﬁrst 2 min of each image
acquisition, the rate-pressure product (RPP) (heart
rate  systolic blood pressure) was derived as an
index of myocardial workload. A decrease in MBF
from mid to mid-distal LV myocardium (ml/g/min)
was deﬁned as longitudinal, base-to-apex MBF
gradient. Alterations in the longitudinal, base-to-
apex MBF gradient from rest to dipyridamole-
stimulated hyperemia were deﬁned as rest-to-stress
change in longitudinal, base-to-apex MBF
gradient (Dlongitudinal MBF gradient ¼ longitu-
dinal MBF gradient during hyperemia – longitu-
dinal MBF gradient at rest). To account for
interindividual variations in coronary driving pres-
sure, an index of coronary vascular resistance (CVR)
was determined as the ratio of mean arterial blood
pressure (mm Hg) to MBF (ml/g/min). As resting
MBF is dependent on the myocardial workload, it
was normalized to the RPP (averaged during the
ﬁrst 2 min of image acquisition; MBF/RPP 
10,000). This again served to calculate
the corrected MFR: (hyperemic MBF during
dipyridamole)/(NMBF at rest).
Statistics. Because continuous variables are not al-
ways normally distributed, they are presented as
median and interquartile range (IQR) (25th to 75th
percentile: quartile 1, quartile 3). For comparison ofdifferences, we used the Mann-Whitney U test for
independent samples (SPSS statistics 22.0, IBM,
Armonk, New York). A comparison of ﬂow pa-
rameters among different myocardial territories was
performed by Kruskal-Wallis 1-way analysis of
variance. Pearson correlation coefﬁcients (r), as-
suming a linear regression and the standard error of
the estimate (SEE), were calculated to investigate
the associations between various ﬂow parameters
and epicardial stenosis diameter, respectively. Using
the Fisher r-to-z transformation, the signiﬁcance of
differences between related correlations was deter-
mined. Receiver-operating characteristic (ROC)
curve with the Youden index (J) was used to deﬁne
the best ﬂow threshold for the Dlongitudinal
MBF gradient and MFR in the detection of
$50% diameter stenosis. The McNemar test was
used to compare the diagnostic accuracy, sensitivity,
and speciﬁcity of ﬂow parameters in the detection
of CAD. All test procedures were 2-sided with
a p value #0.05, indicating statistical signiﬁcance.RESULTS
Clinical characteristics. Table 1 denotes the charac-
teristics of the study population. All patients had a
history of angina pectoris: 20 with suspicion for
Table 2. Myocardial Flow Parameters and Hemodynamics in Control Individuals
and CAD Patients During PET/CT
Control Individuals CAD Patients p Value
Flow parameters
Global MBF
Rest 0.70 (0.65, 0.72) 0.89 (0.76, 1.19) 0.0001
DP 2.16 (1.85, 2.57) 1.29 (1.02, 1.52) 0.0001
Global NMBFdrest 0.95 (0.85, 1.14) 1.00 (0.93, 1.08) 0.528
Global MFR 3.17 (2.81, 3.75) 1.32 (1.17, 1.73) 0.0001
Global corrected MFR 3.51 (2.63, 4.02) 1.27 (1.05, 1.57) 0.0001
Global CVR
Rest 119 (105, 134) 98 (88, 125) 0.010
DP 37 (29, 42) 66 (56, 74) 0.0001
Global DCVR 82 (100, 68) 28 (56, 18) 0.0001
MBF gradient
Rest 0.04 (0.08, 0.04) 0.09 (0.14, 0.01) 0.339
DP 0.09 (0.12, 0.07) 0.28 (0.34, 0.20) 0.0001
DMBF gradient 0.04 (0.07, 0.01) 0.16 (0.28, 0.10) 0.0001
CVR gradient
Rest 9.35 (4.91, 12.74) 5.84 (0.19, 15.28) 0.324
DP 1.50 (1.02, 2.13) 15.01 (8.35, 20.03) 0.0001
DCVR gradient 7.45 (11.54, 3.49) 6.09 (0.31, 17.04) 0.0001
Hemodynamics
Heart rate, beats/min
Rest 63 (59, 70) 71 (63, 79) 0.002
DP 90 (78, 94) 81 (71, 87) 0.009
SBP, mm Hg
Rest 115 (103, 120) 128 (115, 139) 0.001
DP 110 (105, 118) 119 (113, 132) 0.014
RPP
Rest 7,192 (6,600, 7,705) 8,579 (7,873, 10,110) 0.0001
DP 9,375 (9,549, 10,620) 9,252 (8,451, 10,339) 0.765
Values are median (Q1, Q3). p values versus control individuals (Mann-Whitney U test for independent
samples). Corrected MFR ¼ ratio of MBF-DP to NMBF at rest. RPP ¼ HR  SBP.
CT ¼ computed tomgraphy; CVR ¼ coronary vascular resistance (mm Hg/ml/g/min); DP ¼ dipyridamole;
HR ¼ heart rate; MBF ¼ myocardial blood ﬂow (ml/g/min); MFR ¼ myocardial ﬂow reserve;
NMBF ¼ normalized myocardial blood ﬂow (ml/g/min); PET ¼ positron emission tomography; RPP ¼ rate-
pressure product; SBP ¼ systolic blood pressure; other abbreviations as in Table 1.
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390CAD and 4 with known CAD. When a signiﬁcant
epicardial coronary artery lesion during coronary
angiography was deﬁned as $50% diameter steno-
sis, 9 patients had 1-vessel disease, 13 had 2-vessel
disease, and 7 had 3-vessel disease.
Stress-induced myocardial perfusion defects. In 24
patients with suspected and known CAD, 13N-
ammonia PET/CT with stress and rest images
identiﬁed 29 regional reversible perfusion defects
(abnormal SSS $4 and SDS $2). The mean
summed rest score, SSS, and SDS were 1.6  0.9,
7.7  2.3, and 6.1  2.0, respectively. All reversibleperfusion defects on 13N-ammonia PET/CT were
subtended to epicardial lesions $50% diameter
stenosis as evidenced by invasive coronary angiog-
raphy. Five patients had 2 stress-induced perfusion
defects with regional decreases in 13N-ammonia
concentrations $2.5 SDs below the mean in
different myocardial territories on standard polar
map evaluation. On a vessel-based analysis, there
were 21% (6 of 29) mild, 62% (18 of 29) moderate,
and 17% (5 of 29) severe reversible perfusion
defects.
Hemodynamics, global and regional ﬂow parameters.
Resting heart rate, systolic blood pressure, and
corresponding RPP were observed to be higher in
CAD patients than in control individuals (Table 2).
Because MBF commonly follows the RPP during
resting conditions, CAD patients had higher
resting MBFs than control individuals. During
dipyridamole-stimulated hyperemia, heart rate
increased signiﬁcantly from rest in both groups, and
was higher in control individuals. Conversely, there
was a mild and nonsigniﬁcant decrease in systolic
blood pressure during dipyridamole-stimulation in
control individuals, whereas it was signiﬁcant in the
CAD group. Although the RPP during pharma-
cologic vasodilation was comparable among these 2
groups, global hyperemic MBF and MFR were
signiﬁcantly higher in control individuals than in
CAD patients. When the global hyperemic MBF
was related to the mean arterial blood pressure in
order to compensate for possible interindividual
variations in coronary driving pressure, the resulting
estimates of global CVR (mean arterial blood
pressure/MBF) widely mirrored the MBF values at
rest and during pharmacologic vasodilation for each
group studied (Table 2). Thus, differences in cor-
onary driving pressure during pharmacologic vaso-
dilation do not account for alterations in hyperemic
MBF responses.
Longitudinal, base-to-apex MBF gradient. Resting
regionalMBFwas signiﬁcantly lower in themid-distal
than in the mid-LV myocardium in both groups of
control individuals and CAD patients (median
0.62 ml/g/min [IQR: 0.57, 0.69 ml/g/min] vs.
0.68 ml/g/min [IQR: 0.61, 0.72 ml/g/min] and
0.89 ml/g/min [IQR: 0.78, 0.96 ml/g/min] vs.
1.03 ml/g/min [IQR: 0.79, 1.14 ml/g/min],
respectively; p < 0.0001). This resulted in small
and comparable longitudinal MBF gradients at
rest between the 2 groups (Table 2). During
hyperemic MBFs, the decrease in longitudinal
ﬂow from the base to apex direction was more
pronounced in CAD than in control individuals
(median 1.33ml/g/min [IQR: 1.34, 1.63ml/g/min]
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391to 1.12 ml/g/min [IQR: 0.92, 1.42 ml/g/min] and
2.22 ml/g/min [IQR: 1.92, 2.64 ml/g/min] to 2.09
ml/g/min [IQR: 1.85, 2.50 ml/g/min]), which
resulted in a signiﬁcantly higher longitudinal MBF
gradient during pharmacologic vasodilation and
Dlongitudinal MBF gradient in CAD patients
when compared with control individuals (Table 2).
When looking at resting longitudinal ﬂows in the
territory with the stress-induced perfusion defect
(T1) and the territory without stress-induced
perfusion defect but with stenosis $50% (T2) or
without stenosis $50% (T3) (Table 3), regional
MBF was also signiﬁcantly lower in the mid-distal
than in the mid-LV myocardium (p < 0.0001,
respectively). The resting longitudinal MBF
gradient, however, was not signiﬁcantly different
among myocardial territories T1 to T3 (Table 3).
When regional hyperemic MBFs were evaluatedTable 3. Myocardial Flow Parameters in Territories With and Witho
Territory
With PD (T1)
Territory W
PD and
Stenosis ‡5
Regional ﬂow parameters
MBFdrest 0.83 (0.68, 1.13) 1.03 (0.78,
NMBFdrest 0.93 (0.83, 1.09) 1.07 (0.95,
MBFdDP 1.18 (0.85, 1.31) 1.32 (1.15,
MFR 1.19 (1.0, 1.64) 1.28 (1.16,
Corrected MFR 1.24 (0.93, 1.36) 1.22 (1.04,
Longitudinal ﬂow parameters
MBF at rest
Mid-LV segment 0.95 (0.64, 1.15) 1.05 (0.82,
Mid-distal segment 0.89 (0.69, 1.01) 0.93 (0.81,
Gradient 0.02 (0.14, 0.02) 0.07 (0.1
MBF during DP
Mid-LV segment 1.23 (1.04, 1.39) 1.46 (1.15,
Mid-distal segment 1.09 (0.85, 1.22) 1.14 (0.88,
Gradient 0.16 (0.19, 0.11) 0.31 (0.3
DGradient 0.10 (0.14, 0.03) 0.21 (0.3
CVR at rest
Mid-LV segment 100 (84, 129) 93 (74, 1
Mid-distal segment 117 (87, 127) 96 (82, 1
Gradient 4.12 (2.03, 13.6) 6.50 (0.0, 1
CVR during DP
Mid-LV segment 68 (59, 78) 57 (49, 6
Mid-distal segment 78 (64, 92) 72 (62, 8
Gradient 10.84 (6.14, 13.47) 15.50 (11.39
DCVR gradient 3.24 (1.34, 11.67) 11.18 (3.59,
Values are median (Q1, Q3). Territory 1 (T1), stress-induced perfusion defect (PD).
PD and without stenosis $50%. p values according to Mann-Whitney U test for ind
Abbreviations as in Table 2.in T1 to T3 in these CAD patients, they were
signiﬁcantly lower in the mid-distal than in the
mid-LV myocardium. The corresponding longitu-
dinal MBF gradient during pharmacologic vasodi-
lation and the change in longitudinal MBF gradient
from rest to hyperemia deﬁned as Dlongitudinal
MBF gradient (longitudinal MBF gradient during
hyperemia  longitudinal MBF gradient at rest)
progressively increased from T1 to T2 and T3,
respectively (Table 3). Although the longitudinal
MBF gradient during pharmacologic vasodilation
was signiﬁcantly higher in T3 than in T2, it did not
reach statistical signiﬁcance for the Dlongitudinal
MBF gradient. In addition, the longitudinal MBF
gradient during pharmacologic vasodilation and
Dlongitudinal MBF gradient in T3 were signiﬁ-
cantly more pronounced than that observed in
control individuals (p ¼ 0.0001 and p ¼ 0.001)ut Stress-Induced PD During PET/CT
ithout
With
0% (T2)
p Values
(T2 vs. T1)
Territory Without
Both PD and
Stenosis ‡50% (T3)
p Values
(T3 vs. T1)
p Values
(T3 vs. T2)
1.21) 0.099 0.85 (0.74, 1.03) 0.713 0.223
1.24) 0.025 0.99 (0.87, 1.10) 0.505 0.251
1.60) 0.004 1.32 (1.03, 1.68) 0.055 0.753
1.73) 0.192 1.36 (1.25, 1.81) 0.026 0.436
1.68) 0.411 1.23 (1.08, 1.54) 0.446 0.949
1.17) 0.279 0.98 (0.79, 1.13) 0.491 0.466
1.07) 0.323 0.86 (0.74, 1.01) 0.887 0.204
5, 0.0) 0.504 0.09 (0.17, 0.07) 0.144 0.159
1.71) 0.020 1.56 (1.28, 2.0) 0.009 0.379
1.39) 0.441 1.28 (1.03, 1.56) 0.107 0.451
9, 0.23) 0.0001 0.45 (0.56, 0.33) 0.001 0.037
5, 0.10) 0.001 0.39 (0.45, 0.14) 0.002 0.247
10) 0.110 104 (82, 111) 0.449 0.687
11) 0.139 103 (92, 120) 0.641 0.509
2.7) 0.610 7.58 (3.34, 9.91) 0.440 0.834
8) 0.008 63 (48, 67) 0.140 0.680
5) 0.574 77 (58, 104) 0.924 0.704
, 23.81) 0.009 23.60 (12.06, 36.90) 0.027 0.465
19.27) 0.053 17.23 (3.38, 25.29) 0.052 0.568
Territory 2 (T2), no stress-induced PD and stenosis $50%. Territory 3 (T3), no stress-induced
ependent samples.
Valenta et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 4 , 2 0 1 4
Longitudinal Flow and CAD A P R I L 2 0 1 4 : 3 8 7 – 9 6
392(Tables 2 and 3). As regards the post-stenotic Dlongi-
tudinal MBF gradient in T1 and T2, it did not differ
signiﬁcantly among the LAD (n¼ 19), LCx (n¼ 17),
and RCA territories (n¼ 20) (median0.10ml/g/min
[IQR: 0.19, 0.09 ml/g/min] vs. 0.16 [IQR:
0.29, 0.01 ml/g/min] vs. 0.14 [IQR: 0.21,
0.07 ml/g/min]; p¼ 0.960 by analysis of variance).
Correlations between regional MFR, Dlongitudinal
MBF gradient, and epicardial stenosis. To investigate
a possible association between hyperemic ﬂow pa-
rameters and epicardial stenosis, the quantitatively-
measured severity of epicardial stenosis was related
to the corresponding regional post-stenotic Dlon-
gitudinal MBF gradient and MFR, respectively. For
the entire CAD study group with focal lesions
$50% (T1 to T2), the severity of epicardial artery
stenosis closely correlated with the Dlongitudinal
MBF gradient (Fig. 1A). As the Dlongitudinal
MBF gradient may have been affected by interin-
dividual differences in coronary driving pressure, theA
C
Figure 1. Relationship Among DLongitudinal MBF Gradient, DLong
and Severity of Epicardial Stenosis
(A) Correlation between Dlongitudinal myocardial blood ﬂow (MBF) gr
indicate an increase in Dlongitudinal MBF gradient). (B) Inverse correla
percent diameter stenosis (positive values on the y-axis indicate an incr
reserve (MFR), (D) corrected MFR, and percent diameter stenosis. SEE ¼relationship between the Dlongitudinal CVR and
the severity of epicardial artery stenosis was evalu-
ated. As seen in Fig. 1B, there was a less pro-
nounced but still signiﬁcant association between
Dlongitudinal CVR and the stenosis severity. In
regard to the regional MFR, it correlated inversely
and signiﬁcantly with stenosis severity (Fig. 1C),
although this association was less prominent for the
corrected MFR (Fig. 1D). Although the correlation
coefﬁcient of 0.52 between the Dlongitudinal MBF
gradient and epicardial artery stenosis (Fig. 1A) is
stronger than that between regional MFR and
epicardial artery stenosis of 0.40 (Fig. 1C), the
difference between these correlation coefﬁcients did
not reach statistical signiﬁcance (p ¼ 0.198).
Furthermore, we analyzed the relationship be-
tween hyperemic MBF increases and post-stenotic
Dlongitudinal MBF gradient in T1 and T2 (Fig. 2).
As it can be observed, hyperemic MBFs inversely
correlated with the post-stenotic DlongitudinalB
D
itudinal CVR, MFR, Corrected MFR,
adient and percent diameter stenosis (negative values on the y-axis
tion between Dlongitudinal coronary vascular resistance (CVR) and
ease in Dlongitudinal CVR). (C) Correlation between myocardial ﬂow
standard error of the estimate.
Figure 2. Relationship Between Hyperemic MBFs and DLongitudinal
MBF Gradient in the Post-Stenotic Myocardial Territory
Correlation between hyperemic myocardial blood ﬂows (MBFs) and corre-
sponding post-stenotic Dlongitudinal MBF gradient in a 4-quadrant display
(negative values on the x-axis indicate an increase in Dlongitudinal MBF
gradient).
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393MBF gradient (r ¼ 0.29, SEE ¼ 0.16, p < 0.02),
emphasizing the ﬂow velocity as an important
determinant for the extent of Dlongitudinal MBF
gradient. When performing a 4-quadrant analysis, it
can be appreciated that the inverse correlation is
mostly related to the upper-left and lower-right
quadrants. It also appears that the higher the hyper-
emic MBF value, the less is the variability for the
post-stenotic Dlongitudinal MBF gradient (upper-
left quadrant). Conversely, the relationship between
hyperemic MBF and post-stenotic Dlongitudinal
MBF gradient may not exist when regarding the
lower ﬂow range of the post-stenotic Dlongitudinal
MBF gradient (lower- and upper-right quadrant),
suggesting an uncoupling of the post-stenotic Dlon-
gitudinal MBF gradient from hyperemic MBFs.
Diagnostic accuracy of regional MFR and Dlongitudinal
MBF gradient in the detection of CAD lesions. The
ROC for the detection of epicardial stenosis $50% by
regional MFR and Dlongitudinal MBF gradient yiel-
ded an optimal cutoff point of#1.40 and#0.25 ml/g/
min, respectively. When applying this ROC-deﬁned
threshold on a per-vessel basis, the sensitivity, speci-
ﬁcity, NPV, PPV, and diagnostic accuracy of the
Dlongitudinal MBF gradient, MFR, and the com-
bined analysis of both parameters for the detection of
epicardial stenosis are given in Table 4. The sensitivity
of the Dlongitudinal MBF gradient to identify
epicardial lesions was signiﬁcantly higher than for the
regional MFR (88% vs. 71%; p# 0.044) (Fig. 3), and
combining both parameters resulted in an optimal
sensitivity of 100%. As regards the speciﬁcity, it was
nonsigniﬁcantly higher for the Dlongitudinal MBF
gradient than for the regional MFR (81% vs. 63%; p¼
0.134). Applying both ﬂow parameters resulted in an
intermediate speciﬁcity of 75% that was lower than for
the Dlongitudinal MBF gradient (81%) and higher
than for the MFR (63%), but nonsigniﬁcantly (p ¼
1.00). The diagnostic accuracy of the Dlongitudinal
MBF gradient for evaluation of epicardial stenosis was
nonsigniﬁcantly higher compared with the MFR (86%
vs. 70%; p ¼ 0.307). The combined analysis of both
parameters, however, yielded the highest diagnostic
accuracy that was signiﬁcantly higher than those for the
Dlongitudinal MBF gradient and for MFR alone (94%
vs. 86%, p # 0.003; and 94% vs. 70%, p # 0.0002).
D I SCUSS ION
The present study is unique in that it demonstrates a
modest but signiﬁcant association between focal
epicardial stenosis severity and a post-stenotic
Dlongitudinal MBF gradient from the mid to
mid-distal LV myocardium. In CAD patients,therefore, increases in severity of epicardial lesions
were paralleled by a progressive decrease in the
magnitude of a post-stenotic Dlongitudinal MBF
gradient. As intracoronary resistance relates
inversely not only to the vessel diameter, but also to
the velocity of the blood ﬂow according to the
Hagen-Poiseuille law (13,15); advanced epicardial
artery lesions may have offset the post-stenotic
longitudinal MBF gradient during hyperemic
ﬂows due to a stenosis-induced decrease in hyper-
emic ﬂows. And, indeed, the described relationship
between hyperemic MBFs and Dlongitudinal MBF
gradient did not necessarily hold anymore for the
lower range of the Dlongitudinal MBF gradient,
implying an uncoupling of the Dlongitudinal MBF
gradient from hyperemic MBFs when high-grade
CAD lesions were present. The observed decrease
in post-stenotic hyperemic ﬂow, associated with a
relative decrease in intracoronary resistance, there-
fore resulted in a less marked ﬂow gradient than in
those coronary vessels without or with less severe
focal stenotic lesions but with higher hyperemic
ﬂows. The post-stenotic ﬂow gradient, however, is
dependent not only on the severity of the epicardial
stenosis with a reduction in post-stenotic hyperemic
ﬂow, but also on distal artery disease and the extent
of branch disease, as previous investigations
emphasize (3,9,12).
Myocardial perfusion, MFR, and epicardial stenosis.
The visual or semiquantitative assessment of
Table 4. Diagnostic Accuracy of PET/CT-Determined MFR and
DLongitudinal MBF Gradient in the Detection of Epicardial
Stenosis ‡50% in CAD Patients
MFR
DLongitudinal
MBF Gradient Combined
Sensitivity 71 (40/56) 88 (49/56) 100 (56/56)
Speciﬁcity 63 (10/16) 81 (13/16) 75 (12/16)
PPV 87 (40/46) 94 (49/52) 93 (56/60)
NPV 38 (10/26) 65 (13/20) 100 (12/12)
Diagnostic Accuracy 70 (50/72) 86 (62/72) 94 (68/72)
Values are % (n/N) on a vessel-based analysis.
Abbreviations as in Tables 1 and 2.
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394stress-induced regional myocardial perfusion defects
on single-photon emission computed tomography
or PET images commonly signiﬁes the “culprit
lesion” in multivessel CAD, but the hemodynamic
signiﬁcance of the remaining epicardial lesions of
less or intermediate severity may be missed (1). In
principle, this limitation may be overcome by ab-
solute MBF quantiﬁcation with PET, or nowadays
with PET/CT imaging. The ability of PET imag-
ing to concurrently assess regional resting and
hyperemic MBFs with the calculation of the
MFR principally affords the identiﬁcation of the
hemodynamic signiﬁcance of each epicardial lesion
in coronary multivessel disease (4,7,15).
There are several clinical investigations (2,16–18)
that have strived to identify the optimal thresholdSensitivity, Speciﬁcity, and Diagnostic Accuracy of MFR,
dinal MBF Gradient, or Both in the Detection of Epicardial
‡50%
representation of the sensitivity, speciﬁcity, and diagnostic accuracy
n emission tomography–measured MBF hyperemic ﬂow parameters
ection of epicardial stenosis. Abbreviations as in Figure 1.values of hyperemic MBFs or MFR to identify
epicardial lesions. These threshold values of hyper-
emic MBF or MFR, however, are dependent on
the PET methodology, the radiotracer applied for
the assessment of MBF, and the deﬁnition of
morphologically-signiﬁcant epicardial lesions (7,15).
For example, in a recent investigation (16), the
diagnostic value of hyperemic MBF, MFR, and the
relative radiotracer content (mCi/ml) for detecting
coronary stenosis $70% among patients with sus-
pected or known CAD was investigated with 13N-
ammonia PET. A cut-point analysis for sensitivity,
speciﬁcity, and accuracy demonstrated the optimal
MBF criteria for CAD when a hyperemic MBF
threshold value of <1.85 ml/g/min and the best
relative tracer content as <70% maximum was
applied. In addition, an abnormal MFR was deﬁned
as <2.0. Applying these 13N-ammonia PET
perfusion and ﬂow parameters, the ROC analysis in
the evaluation of the diagnostic accuracy of CAD
lesions demonstrated the highest value of 0.90 for
adenosine-stimulated absolute hyperemic MBF,
0.86 for MFR, and 0.69 for 13N-ammonia relative
uptake. In a more recently performed investigation,
Fiechter et al. (2) also used a pre-deﬁned MFR
threshold of #2.0 for predicting CAD lesions with
a luminal narrowing $50%. Employing this pre-
deﬁned threshold of MFR resulted in a sensitivity,
speciﬁcity, and diagnostic accuracy of 96%, 80%,
and 92% for detecting epicardial lesions. In the
current study, we used an ROC-deﬁned threshold
of #1.40 for the MFR for the detection of $50%
diameter stenosis in patients with predominantly
multivessel CAD. Operating this MFR threshold of
1.40 resulted in a sensitivity, speciﬁcity, and diag-
nostic accuracy of 71%, 63%, and 70%, respectively,
in the identiﬁcation of CAD lesions. The relatively
low sensitivity and, in particular, speciﬁcity may be
surprising as compared with a recent investigation
(2), but most likely it is related to the lower
MFR threshold of 1.40 for CAD identiﬁcation
and the presence of more advanced stages of
CAD commonly associated with more pronounced
microvascular dysfunction (7). The latter consider-
ation may agree with the observation that hyperemic
MBFs in the myocardial territories without stress-
induced perfusion defects but with or without ste-
nosis of $50% were comparable. Further support
also comes from recent observations (1) in a cohort
of 120 consecutive patients referred to a dipyr-
idamole 82rubidum PET for the detection of
myocardial ischemia. As it was observed, among
25 patients with severe 3-vessel CAD, MFR was
globally diminished in 22 (88%) of these patients
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395when a MFR threshold of <2.0 was applied. When
applying another radiotracer, such as 15O-water, a
threshold of pharmacologically-induced hyperemic
MBFs of <2.5 ml/g/min was demonstrated to be
most accurate in the identiﬁcation of epicardial le-
sions of >50% diameter stenosis (17). In a more
extended investigation by Kajander et al. (18), 104
patients with moderate (30% to 70%) pre-test
likelihood of CAD underwent 15O-water PET
perfusion imaging. Applying a hyperemic MBF
threshold <2.5 ml/g/min for the detection of CAD
resulted in a sensitivity, speciﬁcity, and diagnostic
accuracy of 95%, 91%, and 92%, respectively, which
are comparable to those values as determined with
13N-ammonia PET using a MFR threshold of <2.0
for CAD identiﬁcation (2).
Longitudinal myocardial ﬂow gradient. In the cur-
rent study, using invasive quantitative coronary
angiography as reference, we performed a ROC
analysis to deﬁne the optimal threshold for the
identiﬁcation of epicardial stenosis $50% by a
Dlongitudinal MBF gradient and corresponding
MFR. Relying exclusively on the Dlongitudinal
MBF gradient and MFR, the ROC analysis
deﬁned thresholds of #0.25 ml/g/min and #1.40,
respectively, to identify CAD lesions. Applying
these thresholds in the current study, the sensitivity
and speciﬁcity of the Dlongitudinal MBF gradient
was signiﬁcantly higher as compared with the
MFR (88% vs. 71% and 81% vs. 63%, respectively).
This also manifested in a higher diagnostic accu-
racy to signify CAD lesions, with 86% for the
Dlongitudinal MBF gradient as compared with
70% when the MFR was applied. In addition,
when combining both quantitative ﬂow parameters
as determined with PET, considering the presence
or absence of epicardial stenosis $50% to be sig-
niﬁcant when identiﬁed by 1 of the 2 ﬂow pa-
rameters, the diagnostic accuracy was signiﬁcantly
increased to 94%. In this direction, the sensitivity
increased to 100%, and the speciﬁcity turned in-
termediate to 75%. Overall, the combined evalua-
tion of both ﬂow parameters yielded the highest
diagnostic accuracy in the evaluation of epicardial
lesions compared with the separate analysis of
Dlongitudinal MBF gradient or MFR. Combining
both ﬂow parameters, therefore, could evolve as a
preferred approach in the evaluation of epicardial
lesions in multivessel disease, but further clinical
validation is needed.
Study limitations. In view of the relatively small
sample size of a selected study population with
suspected (n ¼ 20) and known (n ¼ 4) CAD, thecurrent ﬁndings may be appreciated more as a
“proof principle” study. Conversely, these initial
observations may provide an important framework
to initiate larger clinical trials to draw more deﬁnite
conclusions. Further, MBFs in the mid and mid-
distal LV segments were measured and, thus, the
longitudinal MBF gradient was determined over a
relatively short longitudinal distance aiming to
circumvent confounding count variability in the
basal segments and partial volume effects in the
apical segment on MBF measurements. This, again,
may have led to some underestimation of the lon-
gitudinal MBF gradient during hyperemic ﬂows.
With the advent of PET/magnetic resonance im-
aging (19), an optimal partial volume correction also
in the apical segments appears to be feasible, which
should lead to a more reﬁned assessment of the
longitudinal MBF gradient. Notably, combining
3-dimensional fusion of CT-determined coronary
morphology and myocardial ﬂow on a voxel basis
(18) would also afford reliable measurement of a
longitudinal ﬂow gradient during pharmacologic
vasodilation not only in the post-stenotic myocardial
region, but also before and after a given CAD
lesion. The latter diagnostic approach could hold
promise for the development of a noninvasive frac-
tional ﬂow reserve.
CONCLUS IONS
The observed correlation between focal epicardial
stenosis severity and a post-stenotic Dlongitudinal
MBF gradient further supports the validity and
value of the longitudinal MBF gradient as a
noninvasive index of the severity of epicardial ste-
nosis. Furthermore, the combined evaluation of a
post-stenotic longitudinal DMBF gradient and
corresponding MFR may evolve as a new promising
analytic approach to further optimize the identiﬁ-
cation of CAD lesions in multivessel disease, but
further clinical investigation is needed.
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